Humira

Pharma

AbbVie locks in US pricing deal as it pledges $100B investment

Though not the first pharma to strike a U.S. pricing deal, AbbVie’s new accord is notable for the sheer size of the investment pledge that comes with.

Fraiser Kansteiner Jan 13, 2026 9:15am

drug prices biologics drug costs IRA money cash payment co-pay

Inside the turning tides of the US biosimilar market

Jan 8, 2026 9:00am

AbbVie increases 2025 revenue projection again, now at $60.9B

Oct 31, 2025 12:14pm

AbbVie's Rob Michael collected $18.5M in '24 CEO debut

Mar 11, 2025 1:11pm

As IBD sales boom, AbbVie increases Skyrizi, Rinvoq projection

Jan 31, 2025 11:41am

AbbVie makes 'Rheum for Dialogue' with new patient resource

Nov 18, 2024 10:20am